Alvotech (NASDAQ:ALVOW – Get Free Report) was the recipient of a significant increase in short interest in October. As of October 15th, there was short interest totaling 1,309 shares, an increase of 60.6% from the September 30th total of 815 shares. Based on an average daily trading volume, of 1,621 shares, the short-interest ratio is presently 0.8 days.
Alvotech Price Performance
NASDAQ:ALVOW traded up $0.05 on Monday, reaching $0.30. The stock had a trading volume of 354 shares, compared to its average volume of 4,535. Alvotech has a 1-year low of $0.12 and a 1-year high of $1.50. The stock has a fifty day moving average price of $0.36 and a 200-day moving average price of $0.30.
About Alvotech
Alvotech is a biotechnology company focused on developing and manufacturing biosimilar medicines. Biosimilars are biologic products designed to be highly similar to approved reference medicines and may provide additional treatment options in areas with significant healthcare costs. The company’s portfolio targets therapeutic categories including immunology, ophthalmology, oncology and other chronic conditions.
Alvotech operates an integrated business model that covers biosimilar research, cell-line development, process development, clinical testing and commercial-scale manufacturing.
Further Reading
- Five stocks we like better than Alvotech
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
- 3 Waste Services Stocks With More Growth Than You Might Expect
- Alphabet’s $400 Billion Sell-Off Could Be the Best AI Buying Window Left in 2026
- 3 Tech Stocks Boosting Buyback Capacity in the Face of the Sector’s Recent Tumble
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
